Literature DB >> 15162424

Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells.

Dietmar Zehn1, Cyril J Cohen, Yoram Reiter, Peter Walden.   

Abstract

Dendritic cells are known as the most potent antigen-presenting cells for the induction of T cell-mediated immune responses. To discriminate between the presentation of antigens and the co-stimulatory aspects of this high immunostimulatory capacity, we used recombinant antibodies with T cell receptor-like specificity to detect defined MHC-peptide complexes on living cells. Mature human dendritic cells (mDC) were compared with immature DC (iDC), monocytes, CD4(+) T lymphocytes, melanoma cells, T2 cells and B lymphoblastoid cells for their capacity to present MHC class I-restricted tumor-associated T cell epitopes and were found to display the specific peptides two to six times longer than other cells. The most short-lived peptide had an average half-life of 8.7 h on mDCvs. 3.5 h on B lymphoblastoid cells, while the most long-lived peptide had a half-life of 118.5 h vs. 20.7 h on these two cell types. The decay kinetics of specific MHC-peptide complexes on iDC were among the fastest observed. The high potency of dendritic cells to induce specific T cell responses is thus based, in addition to the expression of co-stimulatory molecules, on an extended antigenic memory, which increases the likelihood and the extent of contacts between dendritic cells and antigen-specific T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162424     DOI: 10.1002/eji.200324355

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Different functional outcomes of intercellular membrane transfers to monocytes and T cells.

Authors:  Kiave-Yune HoWangYin; Estibaliz Alegre; Marina Daouya; Benoit Favier; Edgardo D Carosella; Joel LeMaoult
Journal:  Cell Mol Life Sci       Date:  2010-04       Impact factor: 9.261

Review 2.  Properties and applications of single-chain major histocompatibility complex class I molecules.

Authors:  Eleni Kotsiou; Joanna Brzostek; Keith G Gould
Journal:  Antioxid Redox Signal       Date:  2011-03-31       Impact factor: 8.401

Review 3.  Enhancement of dendritic cells as vaccines for cancer.

Authors:  Meghan E Turnis; Cliona M Rooney
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

4.  Predicting lymph node output efficiency using systems biology.

Authors:  Chang Gong; Joshua T Mattila; Mark Miller; JoAnne L Flynn; Jennifer J Linderman; D Kirschner
Journal:  J Theor Biol       Date:  2013-06-29       Impact factor: 2.691

5.  ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells.

Authors:  Hye Suk Yoon; Christopher D Scharer; Parimal Majumder; Carl W Davis; Royce Butler; Wendy Zinzow-Kramer; Ioanna Skountzou; Dimitrios G Koutsonanos; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2012-07-30       Impact factor: 5.422

6.  CD4/CD8/Dendritic cell complexes in the spleen: CD8+ T cells can directly bind CD4+ T cells and modulate their response.

Authors:  Aleksandr Barinov; Alessia Galgano; Gerald Krenn; Corinne Tanchot; Florence Vasseur; Benedita Rocha
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

7.  Regulation of T cell expansion by antigen presentation dynamics.

Authors:  Andreas Mayer; Yaojun Zhang; Alan S Perelson; Ned S Wingreen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-08       Impact factor: 11.205

8.  Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen.

Authors:  S Guo; J Xu; W Denning; Z Hel
Journal:  Gene Ther       Date:  2009-07-30       Impact factor: 5.250

Review 9.  Functional avidity: a measure to predict the efficacy of effector T cells?

Authors:  Selena Viganò; Daniel T Utzschneider; Matthieu Perreau; Giuseppe Pantaleo; Dietmar Zehn; Alexandre Harari
Journal:  Clin Dev Immunol       Date:  2012-11-20

10.  Mathematical modeling of the immune system recognition to mammary carcinoma antigen.

Authors:  Carlo Bianca; Ferdinando Chiacchio; Francesco Pappalardo; Marzio Pennisi
Journal:  BMC Bioinformatics       Date:  2012-12-13       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.